AICTE sponsored QIP on “Strategies in managing quality of biologicals and biosimilars”
Start Date: September 17, 2018
End Date: September 29, 2018
New regulations, healthcare expenditure cuts and advances in manufacturing techniques have determined the appearance of a new market for biosimilars, which is comparable to that of generic drugs. This QIP will equip the participants with the required expertise and knowledge about the challenging biological and biosimilar molecules.
Objectives of the QIP:
1. To understand the quality specifications and regulations of biosimilar and biologicals.
2. To appreciate the challenges involved in discovery, engineering and evaluation of biopharmaceuticals.
3. To analyse market dynamics of biopharmaceuticals globally.
Registration deadline: 10 September 2018
CLICK here to download the brochure
Golden Jubilee Commemoration Lecture
Dr Kiran Kumar Kolathur receives the best poster award at the 52nd Annual Conference of IPS-2023
Curriculum Conclave “BEYOND CURRICULUM…” held at MCOPS
MCOPS celebrated the 60th Awards and Annual Day
MCOPS Diamond Jubilee Walkathon to Raise Awareness about Childhood Cancer